logo
Plus   Neg
Share
Email

Elanco Animal Health Signs Deal With PetIQ To Divest Capstar

Elanco Animal Health Inc. (ELAN) said it agreed to divest the U.S. rights to Capstar, an oral tablet that kills fleas in dogs and cats, to PetIQ Inc. (PETQ), pet medication and wellness company, for $95 million in an all-cash deal. The product had 2018 revenue of $28.5 million.

Divesting Capstar further advances Elanco's efforts to gain U.S. regulatory clearance for the previously announced acquisition of Bayer AG's global animal health business. The closing of the transaction with PetIQ is contingent on Elanco entering into a consent decree with the Federal Trade Commission in connection with its Bayer transaction, as well as other customary closing conditions.

It is the second divestiture announcement Elanco has made in the last week as it works to bring its acquisition of Bayer's animal health business to a close. Elanco previously announced an agreement to divest Osurnia, a treatment for otitis externa in dogs, to Dechra Pharmaceuticals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT